CYCLOBENZAPRINE HYDROCHLORIDE | A090478 | INVAGEN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.0211
per ea
Lowest NADAC/Unit
$0.0177
per ea
Brand NDCs
0
Generic NDCs
12
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 69097084507CYCLOBENZAPRINE 5 MG TABLET | $0.0211 | EA | Generic | — | 2026-06-17 |
| 50268019015CYCLOBENZAPRINE 5 MG TABLET | $0.0211 | EA | Generic | — | 2026-06-17 |
| 76282028327CYCLOBENZAPRINE 10 MG TABLET | $0.0177 | EA | Generic | — | 2026-06-17 |
| 76282028330CYCLOBENZAPRINE 10 MG TABLET | $0.0177 | EA | Generic | — | 2026-06-17 |
| 76282028360CYCLOBENZAPRINE 10 MG TABLET | $0.0177 | EA | Generic | — | 2026-06-17 |
| 76282028390CYCLOBENZAPRINE 10 MG TABLET | $0.0177 | EA | Generic | — | 2026-06-17 |
Showing 6 of 12 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.